Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Streamlining Radioembolization for Cholangiocarcinoma or Metastatic Liver Cancer ≤ 7 cm : Multicenter Prospective Registry Study

NCT07043387 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT07043387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07043387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Streamlining Radioembolization for Cholangiocarcinoma or Metastatic Liver Cancer ≤ 7 cm : Multicenter Prospective Registry Study
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Recruiting
Start date
June 22, 2025
Completion date
June 30, 2029
Enrollment
60 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, metastatic colorectal carcinoma (mcrc), metastatic liver cancer